Emerging Roles of Chemokines in Cancer Immunotherapy
- PMID: 35892852
- PMCID: PMC9331769
- DOI: 10.3390/cancers14153593
Emerging Roles of Chemokines in Cancer Immunotherapy
Abstract
This series of 15 articles (4 original articles and 11 reviews) is presented by international leaders in chemokine research [...].
Conflict of interest statement
The author declares no conflict of interest.
References
-
- De Zutter A., Crijns H., Berghmans N., García-Caballero M., Vanbrabant L., Pörtner N., Vanheule V., Verscheure P., Siddiquei M.M., Abu El-Asrar A.M., et al. The Chemokine-Based Peptide, CXCL9(74-103), Inhibits Angiogenesis by Blocking Heparan Sulfate Proteoglycan-Mediated Signaling of Multiple Endothelial Growth Factors. Cancers. 2021;13:5090. doi: 10.3390/cancers13205090. - DOI - PMC - PubMed
-
- Erlichman N., Baram T., Meshel T., Morein D., Da’adoosh B., Ben-Baruch A. Correction: Erlichman et al. Tumor Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Human Breast Cancer Are Mediated by PD-L1-S283 and Chemokine Axes. Cancers. 2022;14:1042. doi: 10.3390/cancers14112579. Cancers2022, 14, 2579. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
